Last updated at 23 hours ago
Director
DIN: 06457646
Shailesh Kumar Singh is currently associated with 3 companies in various capacities such as Director and Individual Promoter. They serve as a Director at HONESTAS PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06457646.Shailesh Kumar Singh is currently involved in 2 different roles. Their most recent position is with PANCHATSARAN MEDICARE PRIVATE LIMITED as a Director. The first company Shailesh Kumar Singh was appointed to as a director was HONESTAS PHARMA PRIVATE LIMITED. Shailesh Kumar Singh is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Shailesh Kumar Singh is currently associated with 3 companies in various capacities such as Director and Individual Promoter. They serve as a Director at HONESTAS PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06457646.Shailesh Kumar Singh is currently involved in 2 different roles. Their most recent position is with PANCHATSARAN MEDICARE PRIVATE LIMITED as a Director. The first company Shailesh Kumar Singh was appointed to as a director was HONESTAS PHARMA PRIVATE LIMITED. Shailesh Kumar Singh is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Male
India
Gain instant access to verified contact details.
Current Companies (3)
Current LLPs (0)
Past Companies (0)
2y 5m 1y 3m Interval
Company Name | Designation | Date of Appointment |
---|---|---|
HONESTAS PHARMA PRIVATE LIMITED | Director | 19-Feb-2013 |
GLANIS PHARMACEUTICALS PRIVATE LIMITED | Director | 13-Feb-2014 |
PANCHATSARAN MEDICARE PRIVATE LIMITED | Director | 20-Jan-2023 |
PANCHATSARAN MEDICARE PRIVATE LIMITED | Individual Promoter | 20-Jan-2023 |